2-(Benzylthio)-5-(p-tolyl)-1,3,4-oxadiazole

Catalog No. :
ACLNEP075
CAS No. :
71134-64-0
Molecular Formula :
C16H14N2OS
Molecular Weight :
282.37

IUPAC Name:2-(benzylthio)-5-(p-tolyl)-1,3,4-oxadiazole

2-(Benzylthio)-5-(p-tolyl)-1,3,4-oxadiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg97%$83.00Login to see priceInquiryInquiry
10mg97%$133.00Login to see priceInquiryInquiry
25mg97%$262.00Login to see priceInquiryInquiry
50mg97%$400.00Login to see priceInquiryInquiry
100mg97%$615.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Benzylthio)-5-(p-tolyl)-1,3,4-oxadiazole
IUPAC Name2-(benzylthio)-5-(p-tolyl)-1,3,4-oxadiazole
Molecular FormulaC16H14N2OS
Molecular Weight282.37
SMILESCC1=CC=C(C2=NN=C(SCC3=CC=CC=C3)O2)C=C1
InChI KeyFAQJOZMUTLORRH-UHFFFAOYSA-N
Synonym2-benzylsulfanyl-5-(4-methylphenyl)-1,3,4-oxadiazole;WAY-301158;2-(Benzylthio)-5-(p-tolyl)-1,3,4-oxadiazole;1,3,4-Oxadiazole, 2-(4-methylphenyl)-5-[(phenylmethyl)thio]-
CAS No.71134-64-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACLNEP075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLURC904 route compound structure diagram
    ACLURC90431130-15-1 In Stock
  4. Then
  5. ACLNEP075 route product structure diagram
    ACLNEP07571134-64-0
Inquiry

2. ACLNEP075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLNEP075 route product structure diagram
    ACLNEP07571134-64-0
Inquiry

Comments (0)